Twin Tree Management, LP Amgen Inc Put Options Transaction History

Twin Tree Management, LP

14 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 12, 2024	SELL	$309.38 - $337.38 $135 Million - $147 Million	-435,900 Reduced 63.16%	254,300 $81.9 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $181 Million - $220 Million	690,200 New	690,200 $216 Million
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $52.2 Million - $58 Million	-226,100 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$219.27 - $242.57 $3.68 Million - $4.08 Million	-16,800 Reduced 6.92%	226,100 $54.7 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $40 Million - $47.6 Million	184,900 Added 318.79%	242,900 $55.8 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $2.35 Million - $2.61 Million	10,000 Added 20.83%	58,000 $14.7 Million
Q2 2020 Aug 12, 2020	SELL	$197.81 - $242.74 $2.02 Million - $2.48 Million	-10,200 Reduced 17.53%	48,000 $11.3 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $10.1 Million - $12.1 Million	58,200 New	58,200 $11.3 Million
Q2 2019 Aug 12, 2019	SELL	$166.7 - $195.41 $3.87 Million - $4.53 Million	-23,200 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$180.87 - $203.88 $3.87 Million - $4.36 Million	-21,400 Reduced 47.98%	23,200 $4.41 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $1.75 Million - $2.04 Million	9,800 Added 28.16%	44,600 $8.68 Million
Q1 2018 May 09, 2018	BUY	$169.43 - $198.0 $5.9 Million - $6.89 Million	34,800 New	34,800 $5.93 Million
Q4 2017 Feb 09, 2018	SELL	$168.79 - $188.59 $3.31 Million - $3.7 Million	-19,600 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $3.28 Million - $3.74 Million	19,600	19,600 $3.65 Million

3,119

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $152B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

Stay updated on Twin Tree Management, LP with notifications on news.